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ROSAbstract Apoptosis is a signiﬁcant physiological function in the cell. P53 is known as tumor
suppressor cellular factor, executive caspases are also the most involved pathway for apoptosis.
Menadione (VK3) has apoptotic action on many harmful cells, but the molecular role of adipokines
is not studied enough in this regard, so the ability of menadione to modify the adipokine (leptin
hormone), caspase-3 and P53 signals to induce its apoptotic action on HepG2 cells was studied.
The study revealed that menadione has anti-viability and apoptotic effect at sub-G1 phase of
HepG2 cell cycle. Its cytotoxic effect is mediated by molecular mechanisms included: inhibiting
leptin expression and level, activating caspase-3 pathway and up-regulating the expression of P53.
Menadione exerts its apoptotic mechanisms in a concentration and time dependent way through
ROS generation. In addition to the known apoptotic pathways, the results indicate that suppressing
leptin pathway is a signiﬁcant mechanism for menadione apoptotic effect which made it as a poten-
tial therapeutic vitamin in preventing hepatocyte survival and proliferation.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Vitamin K is an important nutritional factor contributing to
the blood clotting process, its different types possess an inhib-
iting growth effect on many tumor cells types in vivo, studies
showed that menadione (Vitamin K3) has potent inhibition ef-
fect on cell growth more than K2 and K1 (Wu et al., 1993;
Lamson and Plaza, 2003; Hitomi et al., 2005). Previous studies
considered menadione as apoptosis (programmed cell death)and antitumor inducing factor on hepatic cells (Tong et al.,
1997; Hitomi et al., 2005). Among many agents Baran et al.
(2012) reported that menadione is a potent inducer of apopto-
sis. It shows cytotoxic effects in many types of tumor cells
(Suresh et al., 2013). P53 (Tumor suppressor transcription fac-
tor) has an essential physiological role in cell growth regulation
by its apoptotic function in the cells to achieve balanced
growth. At normal circumstances, P53 expression is low be-
cause of its limited needs which result in its speed inactivation
but it has an ability to be more stable, active and accumulative
in response to activator signals such as DNA destruction, then
its transcriptive and expression level increase leading to distur-
bance in the cell cycle which revealed the apoptotic features
(Naderi et al., 2009). P53 prevents tumor evolution and pro-
gression and activates death of cells subjected to anti-tumor
therapy which made P53 as ‘‘guardian angel’’ as described by
Royds and Iacopetta, 2006. In addition to P53, caspases in
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pase-3 is the most involved pathway which should be gener-
ated from its inactive protein (procaspase-3), caspase 3 is
required for some apoptosis features (chromatin condensation,
DNA damage and apoptotic body formation) and its role may
take place before cell viability suppression starts (Porter and
Ja¨nicke (1999). Caspases also have an apoptotic effect on
hepatocellular carcinoma (HepG2) which was stimulated by
caspase-3 gene expression (Tong et al., 1997). On the other
hand, data of Samali et al. (1999) revealed that menadione in-
duces necrosis in HepG2 cell line and suppresses Caspase
activity by generation of H2O2 and this oxidative stress model
could suppress cell death by apoptosis, but reducing the levels
of ROS by catalase reversed the inhibitory effect of menadione
on Caspase activity. Bonilla-Porras et al. (2011) conﬁrmed that
treatment leukemia cells with VK3 and VC individually or
together activated apoptosis by molecular signals included
ROS generation, activation transcription factors included
P53, depolarization of the mitochondria and activation of cas-
pase-3 pathway. It is found also that VK2 and VK3 have an
arresting effect on human hepatocellular carcinoma cell cycle
at G1 (Hitomi et al., 2005) but Quercetin is one of the ﬂavo-
noids which decreased apoptosis and prolonged cell cycle
phase G2/M arrest stimulating by radiation (Baran et al.,
2012). In contrast, it seems that leptin (the adipose tissue
hormone involved in energy metabolism) has anti- apoptotic
effect, it could induce glial viability in dose dependent manner,
but cannot abolish H2O2 induced oxidation in primary mixed
glial cell (Kabadere et al., 2007). Leptin also stimulated ovar-
ian cancer cell line growth through up-regulating the genes
and proteins required for cell proliferation as well as down-
regulating the factors related to its pro-apoptotic effect (Ptack
et al., 2013). Recent study originated connection’s model be-
tween adipose tissue and hepatocytes (Nishijima-Matsunobu
et al., 2013). Menadione has selective effect, Suresh et al.
(2013) reported that menadione is a potential candidate in oral
cancer therapy because of its high cytotoxic effect on oral
squamous carcinoma cells (SAS) but not on non-tumorigenic
cells (HEK293 and HaCaT), in SAS, menadione treatment in-
creased expression of apoptosis regulator (Bax and p53) as
pro-apoptotic proteins and at the same time decreased anti-
apoptotic proteins such as Bcl-2 and p65. Goldstein et al.
(2013) described the mechanism which made p53 an inhibitor
of tumorigenesis in liver cells. Menadione is a well known cyto-
toxic agent which has potential role against many cancer cell
lines. Therefore this study was conducted to highlight its sup-
pressing effect on HepG2 cell viability as well as to evaluate
the potential molecular signaling involved in apoptosis, to be
presented as a possible apoptotic approach in preventing liver
cell survival and proliferation.
2. Materials and methods
2.1. Cell culturing and treatment
Hepatocellular carcinoma (HepG2) cells were obtained from
American Type Cell Culturing (ATCC HB-8065) and incu-
bated in moistened environment at 37 C and 5%CO2, the cells
were cultured at a density of 5 · 105 in DMEM medium mixed
with L-glutamine, supplemented with fetal bovine serum (FBS),
penicillin Streptomycin (Gibco, Invitrogen Corporation,USA). After 70% cell gathering, the cells were sub cultured
using a standard trypsin-EDTA method. After cell culturing
and conﬂuence (Lu et al., 2008; Lee et al., 2012; Yeo et al.,
2012), HepG2 cells were treated with different concentrations
of menadione for different periods as described below.
2.2. Effect of menadione on cell viability
Cells viability was determined by MTT assay (3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyl tetrasodium bromide) (Mosmann,
1983), the HepG2 cells were cultured into 96 well microtiter
plates at a density of 2 · 105 cells per well. After 24 h the media
were incubated with different concentrations of menadione
(Sigma Aldrich) for 24 h, then treated with MTT reagents
and other involved solutions. After removing unbound stain,
the blue formazan crystal compound was dissolved, its absor-
bance was measured on an ELISA reader at 570 nm. Control
growth is considered 100%, viability % was calculated (sam-
ple/control · 100) (Hsu and Yen, 2006). The cell culture was
repeated to assess dose dependent effect of menadione using
concentration of 5, 10, 20 and 40 lM for 24 h. 10 lM menadi-
one was used to investigate time dependent effect (for periods
6, 12, 24 and 36 h) and for further assays.
2.3. Menadione apoptotic assay by FACS
After treatment with (10 lM) menadione at indicated time, cell
cycle progress was analyzed by Fluorescence activated cell sor-
ter (FACS), the media were centrifugated to collect the cells,
then ﬁxed, the cell suspension was kept at 4 C for overnight
to stain the fragmented molecules of DNA with Propidium
iodide (PI) reagents, the stained DNA was analyzed by ﬂow
cytometer (Becton Dickinson) (Lee et al., 2012).
2.4. Western blotting for molecular signal detection
Post treatment with menadione at the indicated time as de-
scribed above, the cells were washed with ice-cold 1· PBS
and collected. After gathering, the cells were centrifuged, and
then total protein was extracted using lysis buffer which was
added to re-suspend and subjected to ultrasonication and then
cells were centrifuged to separate cell debris. The supernatant
was kept at 20 C until further use (Reyes-Leon et al.,
2007; Naviglio et al., 2009). Immuno blotting was carried
out using antibodies against p53 (sc-99), caspase-3 (sc-7148),
leptin (ab3583) and b-actin (sc-47778) (Santa Cruz Biotechnol-
ogy and Abcam).
2.5. Measurement of ROS generation
Intracellular ROS generation was evaluated by the oxidant-
sensitive ﬂuorescent probe, DCFHDA and inverted micro-
scope. HepG2 cells were incubated at a density of 2 · 105 cells
per dish and pretreated for 2 h with or without N-acetylcyste-
ine (NAC), and then treated with menadione (10 lM) for 24
and subjected to 5 lM H2DCFDA for 20 min and washed
with 1· PBS. An inverted microscope (Zeiss Axiovert 200)
was used for imaging DCF ﬂuorescence (excitation 480 nm
and emission 520 nm) Lee et al., 2012; Yeo et al., 2012).
H2DCFDA was purchased from Invitrogen Molecular Prob.
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After incubation with 10 lM menadione, cell culture was
washed with cold 1· PBS and treated with lysis buffer, the con-
tents of the wells were pooled and centrifuged at 4 C. The
reaction buffer was incubated with the supernatant which also
incubated with colorimetric agent Ac-DEVD-pNA (caspase-3
substrate) (Promega) at 37 C for 1 h. Absorbance (A) of
Caspase activity was measured at 405 nm, it was calculated
according to ‘‘A/mg of protein in menadione treated sample/
(A/mg of protein in control sample)’’ (Kil et al., 2007;
Thayyullathil et al., 2013).
2.7. Leptin assay
A speciﬁc Kit from Cayman Chemical was used for assaying
human leptin as described by Wu et al. (2007). The concentra-
tion of leptin in the supernatant of menadione treated HepG2
cell culture media was measured as per the manufacturer’s
instruction based on a double-antibody sandwich principle.
Incubation with speciﬁc antibodies for 60 min was done twice,
at ﬁrst, 50 ll from culture media was added to 96-wells to
incubate with pre-coated solid polyclonal antibody at roomMenadione con
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Figure 1 (A) HepG2 cells were incubated with different concentratio
MTT assay. Data present mean ± SD, where pP 0.05. (B) HepG2 cel
viability was assessed by MTT assay. Data present mean ± SD, whertemperature, after shaking, and washing with washing buffer
then the second incubation was run with peroxidase-
conjugated anti-leptin antibody. The unbound reagents were
removed by washing while the absorbance of the bound dou-
ble-antibody complexes was measured spectrophotometrically
at 450 nm.
2.8. Statistical analysis
The assays were carried out three times for the statistical
evaluation. Data were introduced as mean ± SD, analysis of
variance and LSD were done by SPSS ver. 19. P< 0.05 was
considered for signiﬁcance differences.
3. Results
3.1. Cytotoxicity of menadione on HepG2 cells
Menadione inhibits HepG2 cell viability. The cytotoxicity of
menadione on HepG2 cells was evidenced by its ability to
reduce the cell viability with concentration increasing as shown
in Fig. 1A. LSD test showed signiﬁcantly that most HepG2
cells were dead after incubation with 20, 40 lM for 24 h, socentrations (µM) 
10 µM                        20 µM 40 µM 
time with menadione10 µM  (hours)  
ns (5–40 lM) of menadione for 24 h. Cell viability was assessed by
ls were incubated with menadione (10 lM) for indicated time. Cell
e pP 0.05.
Menadione apoptotic effect on HepG2 cells 58510 lM was selected for menadione time dependent effect, it
showed an inhibitory action on cell viability and increases with
time at P< 0.05 as shown in Fig. 1B. The dose was also used
for further assays.3.2. Menadione induced time dependent apoptosis
HepG2 cells were treated with 10 lM menadione for 3, 6, 12
and 24 h and staining with PI, then the cell’s DNA content
was analyzed by ﬂow cytometry. FACS assay showed that
menadione increased cell fraction at sub-G1 phase in a time
dependent way (Fig. 2A).3.3. Meadione modiﬁes molecular leptin and other signals
expression
Menadione treatment decreases leptin expression (Fig. 4B),
while there was an up-regulation in the expression of P53
with increasing time (Fig. 2B). The results also revealed
activation in caspase-3 in a time-dependent manner at
protein level as the enzyme cleavages from its inactive form
pro-caspase 3, which exhibited a decrease in its expression
(Fig. 3B).3.4. Menadione activiates caspase-3
Post 10 lM menadione treatment, caspase-3 activity of the
treated sample was elevated in a time dependent way com-
pared with control sample as shown in Fig. 3A.3.5. Menadione decreases leptin levels
Leptin levels in menadione treated culture media were
measured by ELISA and revealed that menadione (10 lM)
decreased leptin levels in a time dependent way (Fig. 4A).0
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Figure 2 (A) HepG2 cells were treated with 10 lM of menadione fo
analyzed by FACS. Menadione increases cell fraction at sub-G1 phas
sub-G1 apoptotic cells (%) were placed in the graph against the indica
pP 0.05. (B) At the indicated time, menadione (10 lM) treatment ind
b-actin level is used as a loading control.3.6. ROS generation by menadione
Cell ﬂuorescence was imaged by an inverted microscope and
revealed that 10 lM menadione alone induces oxidative stress
in HepG2 cells compared with control cells while treatment of
cells with (menadione – pre treated with NAC) followed by
incubation with H2DCFDA reversed menadione ROS genera-
tion effect as shown in Fig. 5.
4. Discussion
It has been shown that menadione has cytotoxic effect on
many harmful cells types, but some certain signals for its mech-
anism of action are not fully studied such as the adipokine lep-
tin molecular signal in association with other proapoptotic
factors. The study conﬁrmed menadione viability reducing
effect on HepG2 cells which agreed with the ﬁnding of Chen
and Cederbaum (1997) who found the cytotoxic effect of
menadione on HepG2 cells. Also Wu et al. (1993) showed that
VK3 antiproliferative activity was more potent than VK1 and
VK2 in many cell lines including HepG2 cells by two assays
(MTT and SRB (sulforhodamine B). Such action was reported
for VK2 and VK3 on human hepatocellular carcinoma
(Hitomi et al., 2005).
MTT assay showed that the viability of HepG2 decreased
with increasing concentration of menadione, 10 lM concentra-
tion was used for time dependent effect and further analysis.
Our result indicated that menadione has an antiviability effect
on the cells in a concentration–time dependent way, the result
agreed with Sata et al. (1997). Concentrations more than
10 lM were not used in order to prevent any potential side ef-
fects because Sata et al. (1997) found that although menadione
at low concentration 1–20 lM and time dependent way inhib-
ited cell proliferation and caused apoptosis evidenced by DNA
indicative indicative but higher concentration of menadione
(100 lM) revealed cell death more than 90% during 4 h and
caused necrosis.24 h 
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Figure 3 Shows the ability of menadione to activate caspase 3 signal pathway. (A) Menadione induces caspase-3 activity in a time
dependent way after incubation HepG2 cells with the enzyme substrate. Data express mean ± SD at pP 0.05. (B) At the indicated time,
menadione treatment decreases procaspase-3 expression, which is an indicative for casapse-3 activation in a time-dependent manner.
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Figure 4 Menadione inhibits leptin pathway. (A) Leptin levels in menadione treated HepG2 cell culture media were measured by ELISA
and revealed that menadione (10 lM) decreases leptin levels in a time dependent way. (B) Also Western blot analysis demonstrated a
decrease in leptin expression with time.
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Figure 5 Shows that menadione (10 lM) alone induced ROS generation in HepG2 cells compared with control cells. But treating the
cells with NAC followed by 10 lM menadione inhibited ROS generation.
586 E. Al-SuhaimiFACS assay showed that menadione increased cell fraction
at sub-G1 phase in a time dependent way which made it as an
apoptotic agent on HepG2, the result coincides with its potent
antitumor effects on human hepatocellular carcinoma by
inducing cell cycle arrest at G1 phase (Hitomi et al., 2005), also
incubation of human bladder tumor cells with combination of
Vitamins C and K3 induced antitumor activity and arrested
the cell growth at the G0/G1-S-phase (McGuire et al., 2013).
Our study conﬁrmed that menadione induces cell apoptosis
by activation of caspase 3 signal. Caspases are found as inac-
tive pro-enzymes, once the initial signal of caspase activationhas been triggered, inactive forms (certain procaspases in-
cludes procaspases-3) are subjected to proteolytic steps to
produce the active form (Earnshaw et al., 1999; Alnemri
et al., 1996; HGNC, 1504), the proteolytic process which could
explain the disappearance of procaspase 3 expression and the
increase in caspse-3 activity with increasing time observed in
this study after incubating HepG2 cells with 10 lM menadi-
one. Cleavage of the active form of the enzyme is a conversion
that allows initiation of apoptosis in colon tumor cells (Putt
et al., 2006). So procaspase-3 cleavage was used as an
apoptotic indicator (Kato et al., 2013), our results harmonize
Menadione apoptotic effect on HepG2 cells 587with those of Tong et al. (1997) who found that VK3 inhibits
the proliferation of HepG2 and induces apoptosis through cas-
pase-3 signal, and with ﬁndings of Hu et al. (2006) who found
that procaspase-3 was signiﬁcantly decreased after treatment
with oroxylin A causing apoptosis in HepG2 cells, the authors
described it as a promising antitumor drug. Also pro-caspase-3
expression was reduced and activation of caspase-3 increased
by Berberine in HepG2 cells (Hyun et al., 2010). It was noticed
in this study that the decrease in procaspase-3 expression and
increasing caspase-3 activity in a time dependent way after
menadione treatment are coincided with decreasing viability
of hepG2 cells, these results may attributed to the enzyme ac-
tion before or at the phase when loss of cell viability occurs
(Porter and Ja¨nicke, 1999). Also Putt et al. (2006) found that
procaspase-3 concentration was signiﬁcantly higher in certain
tumor cells than that in non-tumor control cells, and they
concluded that the activation of the executioner caspases is
considered a beneﬁcial approach in treating many tumors
characterized by high levels of procaspase-3.
Immunoblotting analysis demonstrated that menadione has
up-regulating effect on P53 expression which corresponds with
cell apoptosis in a time dependent manner, these results agreed
with the signiﬁcant role of P53 in the regulation of cell cycle
and growth described by previous study (Erlacher et al.,
2005). It is worth to mention that menadione apoptotic effect
depends on its concentration, Sata et al. (1997) reported that
low levels (1–20 lM) of menadione induced wild type P53,
but (100 lM) had a little effect on it and induced necrosis.
P53 may be considered as an inhibitor of tumorigenesis
through its ability in regulating glucose release in both human
liver cells and primary mouse HepG2 cells (Goldstein et al.,
2013). In contrast, other vitamin like VD compounds activate
apoptosis through inhibition of caspase and p53 pathway
(Erlacher et al., 2005).
Leptin is an anti-obesity hormone. Obesity is considered a
signiﬁcant factor for hepatocellular carcinoma complicated
with some liver diseases, leptin prevented apoptosis by ethanol
(Balasubramaniyan et al., 2007), our results indicated that
menadione apoptotic action on HepG2 cells is mediated by
inhibiting leptin expression and decreasing its levels at the indi-
cated time, the result coincides with recent researches in obese
individuals, their data indicated the beneﬁt of inhibiting leptin
signals in preventing breast cancer (Gillespie et al., 2012), also,
leptin seems to be an antiapoptotic hormone and the correla-
tion between ovarian cancer risk and high leptin levels should
be considered in obese women (Ptack et al., 2013). Our result
indicated that menadione promotes HepG2 cells apoptosis
depending on leptin- signal suppressing.
NAC is a well known antioxidant and inhibitor of intracel-
lular ROS (Sun, 2010). Therefore we used NAC in the current
experiment as negative control to assure menadione speciﬁc
effect in ROS generation, so we conﬁrm the inverting effect
of menadione by addition of NAC before treating the cells
with menadione. The results showed that 10 lM menadione
apoptotic action is mediated by inducing oxidative stress in
HepG2 cells, while treating the cells with NAC inhibited men-
adione ROS generation effect in this study, the result agreed
with study of Chen and Cederbaum (1997), also is supported
by data of Koka et al. (2010) who found that pretreatment
prostate cancer cell with NAC suppressed thymoquinone-
ROS generation inducing and growth inhibition effects.
Although the current study conﬁrmed that menadionesuppresses the cell viability by activation caspase-3 and ROS
pathways, but in contrast Samali et al. (1999) found that men-
adione inactivates caspase by the generation of H2O2 which
may prevent cell death. The results concluded that menadione
has a dose and time dependent anti- viability effect by
suppressing leptin pathway and activation caspase 3 and P53
signals depending on ROS generation. It is worth to mention
that leptin should be focused in the apoptosis studies because
of its opposite direction to apoptosis. So regulating leptin, cas-
pase-3 and P53 molecular signals by medical nutrition may be
of signiﬁcant beneﬁt in managing anti-proliferative therapy.Acknowledgments
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